BC Platforms provides genomic data discovery and analytics platforms that convert complex biological information collected in healthcare settings into actionable insights. Its platform harmonises and manages data from diverse biobanks and healthcare institutions, making it accessible to pharmaceutical and biotech companies to support research and development. In parallel, the company enables patient stratification toward targeted therapies to advance more personalized healthcare. The platform supports flexible data integration, secure analysis, and interpretation of molecular and clinical information. Led by CEO Tero Silvola, BC Platforms is expanding its R&D and commercial capabilities. The company is already present in the US, the UK, Finland, Switzerland, and Singapore. BC Platforms provides genomic data management and analysis solutions and has launched a global biobank network called BCRQUEST.COM to supply genomic and clinical cohort data for pharma and medical R&D. The company plans to use the $15M funding to expand its global network of clinical and genomics data and to deliver novel automated solutions to pharmaceutical companies. It announced a commercial collaboration with IQVIA to launch data-driven technologies that integrate complex clinical and genomic data. IQVIA’s investment includes a designee on BC Platforms’ board of directors. BC Platforms has partnerships with approximately 100 enterprise-level healthcare systems and biobanks across 25 countries and recently established an entity in Singapore to lead its Asian activities. The company was founded in 1997 from an MIT Whitehead project spinoff, is headquartered in Zurich, and maintains R&D in Espoo with sales and marketing in London, Boston, Vancouver and Singapore; Tero Silvola is CEO. BC Platforms provides a genomic data management platform that enables integration, analysis and interpretation of molecular and clinical information. The company’s core product serves academic and hospital research groups as well as pharmaceutical and agricultural companies. It currently provides solutions to over 50 international institutions in 19 countries. BC Platforms plans to use the new funding to launch technologies in 2017 that integrate complex clinical and genomic data and to grow its genomic data management software business worldwide. The company was founded in 1997 and is led by CEO Tero Silvola. BC Platforms has global operations with headquarters in Basel, R&D in Helsinki, and sales and marketing in London, Boston, and Vancouver.

Total raised

$45M

Funding rounds

3

Latest round

Equity

Latest activity

Nov 2022